NEW FOLLOW-UP STUDY SHOWS THAT A NATURALLY OCCURRING COENZYME NUTRITIONAL SUPPLEMENT ENADA® NADH CLINICALLY DEMONSTRATES BENEFITS FOR ALZHEIMER’S PATIENTS To read the study please click this link : Nov 2002 ICMAN Study on Alzheimers 2nd International Conference on Mechanisms and … Continued
Objective: To evaluate the effect of stabilized oral NADH (reduced nicotinamide adenine dinucleotide; ENADA®) on cognitive functioning in patients with AD. To read the study please click this link : 2002 Treatment of Alzheimers Double Blind Study Treatment of … Continued
Summary: This study was designed to evaluate the effect of stabilized oral reduced nicotinam,de adenine din ucleotide (NADH) on cognitive functioning in patients with Alzheimer’s dsease (AD). NADHis a coenzyme that plays a key role in cellular energy production and … Continued
Although significant progress has been achieved in revealing the etiology of AD, the search for efficient therapy stays the man goal. Nicotinamide adenine dinucleotide (NADH) is biologically identified as a cofactor necessary for a number of cellular actions, such as … Continued
NADH is a strongly reducing agent and has been suggested to act – possibly by indirect means – as important antioxidant. Only recently direct antioxidative effects of NADH were demonstrated and NADH was suggested as major antioxidant in mitochondria. Click … Continued
Enada Co-E1 ( NADH) ( since 1993 ) is of vital importance to the world in general for good health support and it affects the body in a myriad of ways on a positive level. As Sir John Eccles, who won … Continued